Bexarotene in combination with chemotherapy fails to prolong survival in patients with advanced non-small-cell lung cancer: Results from the SPIRIT I and II trials

被引:13
作者
不详
机构
[1] Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
[2] Lung and Thoracic Malignancies Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA
关键词
D O I
10.1016/S1525-7304(11)70385-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:17 / 19
页数:3
相关论文
共 8 条
[1]  
Blumenschein GR, 2005, J CLIN ONCOL, V23, p621S
[2]  
Jassem J, 2005, J CLIN ONCOL, V23, p627S
[3]   Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial [J].
Kelly, K ;
Crowley, J ;
Bunn, PA ;
Presant, CA ;
Grevstad, PK ;
Mainpour, CM ;
Ramsey, SD ;
Wozniak, AJ ;
Weiss, GR ;
Moore, DF ;
Israel, VK ;
Livingston, RB ;
Gandara, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3210-3218
[4]   Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer [J].
Khuri, FR ;
Rigas, JR ;
Figlin, RA ;
Gralla, RJ ;
Shin, DM ;
Munden, R ;
Fox, N ;
Huyghe, MR ;
Kean, Y ;
Reich, SD ;
Hong, WK .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2626-2637
[5]  
*LIG PHARM, TARGR
[6]   Initial clinical trial of a selective retinoid X receptor ligand, LGD1069 [J].
Miller, VA ;
Benedetti, FM ;
Rigas, JR ;
Verret, AL ;
Pfister, DG ;
Straus, D ;
Kris, MG ;
Crisp, M ;
Heyman, R ;
Loewen, GR ;
Truglia, JA ;
Warrell, RP .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :790-795
[7]  
Rizvi NA, 1999, CLIN CANCER RES, V5, P1658
[8]   Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J].
Schiller, JH ;
Harrington, D ;
Belani, CP ;
Langer, C ;
Sandler, A ;
Krook, J ;
Zhu, JM ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02) :92-98